Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
NAFLD & NASH Treatment in Primary Care: 8 Questions based on AASLD Guidance
Weight loss for patients with NAFLD is the key to improvement of histopathologic features. Find out what else you know about treatment of NAFLD/NASH with 8 guidance-based questions.
The American Association for the Study of Liver Diseases (AASLD) outlines a data‐supported approach to the treatment nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in a guidance document published in Hepatology.
While disease-specific pharmacotherapy is still in clinical trials, there are a number of recommended approaches to management using existing medications and non-drug intervention. Find out what you know about these with the following 8 questions.
Recent Videos
Related Content
